Interpharm Holdings (Interpharm Holdings) EV-to-EBITDA : 0.00 (As of Jun. 22, 2024)

Interpharm Holdings EV-to-EBITDA Chart

Interpharm Holdings Annual Data
	Trend	Jun98	Jun99	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07
EV-to-EBITDA		Get a 7-Day Free Trial					-	13.12	42.62	-18.16	-13.61

Interpharm Holdings Quarterly Data
	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07
EV-to-EBITDA	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Interpharm Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Interpharm Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's EV-to-EBITDA falls into.

Interpharm Holdings EV-to-EBITDA Calculation

Interpharm Holdings's EV-to-EBITDA for today is calculated as:

Interpharm Holdings's current Enterprise Value is $0.00 Mil.
Interpharm Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interpharm Holdings  (GREY:IPAH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Interpharm Holdings's PE Ratio for today is calculated as:

Interpharm Holdings's share price for today is $0.0001.
Interpharm Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.510.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Interpharm Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Interpharm Holdings (Interpharm Holdings) Business Description